STSA

Satsuma Pharmaceuticals, Inc. Common Stock

Delisted

STSA was delisted on the 7th of June, 2023.

31 hedge funds and large institutions have $12.7M invested in Satsuma Pharmaceuticals, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 9 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
31
Holders Change
-2
Holders Change %
-6.06%
% of All Funds
0.5%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
5
Increased
6
Reduced
9
Closed
7
Calls
$145K
Puts
Net Calls
+$145K
Net Calls Change
-$115K
Name Holding Trade Value Shares
Change
Shares
Change %
Morgan Stanley
26
Morgan Stanley
New York
$5.54K -$2.27K -3,251 -29%
Citadel Advisors
27
Citadel Advisors
Florida
$3.77K -$3.15K -4,515 -46%
UBS Group
28
UBS Group
Switzerland
$1.27K +$1.27K +1,815 New
Group One Trading
29
Group One Trading
Illinois
$311 -$89 -127 -22%
Wells Fargo
30
Wells Fargo
California
$130 +$2 +3 +2%
Citigroup
31
Citigroup
New York
$6
DCM
32
Driehaus Capital Management
Illinois
-$735K -816,902 Closed
Dimensional Fund Advisors
33
Dimensional Fund Advisors
Texas
-$209 -231,417 Closed
Millennium Management
34
Millennium Management
New York
-$157K -174,994 Closed
CPIG
35
Chicago Partners Investment Group
Illinois
-$54.3K -63,863 Closed
Susquehanna International Group
36
Susquehanna International Group
Pennsylvania
-$49K -54,419 Closed
TSS
37
Two Sigma Securities
New York
-$22.5K -24,972 Closed
Fidelity Investments
38
Fidelity Investments
Massachusetts
-$41 -45 Closed